Diosgenin protects against podocyte injury in early phase of diabetic nephropathy through regulating SIRT6
Open Access
- 13 June 2022
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 104, 154276
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81874382, 81904010, 81904158, 82004200, 82174159)
This publication has 41 references indexed in Scilit:
- Diabetes and Kidney Disease: Role of Oxidative StressAntioxidants & Redox Signaling, 2016
- Renoprotective effect of diosgenin in streptozotocin induced diabetic ratsPharmacological Reports, 2016
- Diabetic kidney diseaseNature Reviews Disease Primers, 2015
- Oil Red O and Hematoxylin and Eosin Staining for Quantification of Atherosclerosis Burden in Mouse Aorta and Aortic Root2015
- Isolation and prevention of calcium oxalate-induced apoptotic death and oxidative stress in MDCK cells by diosgeninChemico-Biological Interactions, 2014
- Modulatory Effects of Diosgenin on Attenuating the Key Enzymes Activities of Carbohydrate Metabolism and Glycogen Content in Streptozotocin-Induced Diabetic RatsCanadian Journal of Diabetes, 2014
- Discovery of Novel and Selective SIRT6 InhibitorsJournal of Medicinal Chemistry, 2014
- Inflammation and the pathogenesis of diabetic nephropathyClinical Science, 2012
- Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKβ and IRS-1 pathwaysAtherosclerosis, 2012
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001